Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02332668 |
|---|---|
| Brief Title: | A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) |
| First Submitted : | January 6, 2015 |
| First Submitted that Met QC Criteria : | January 6, 2015 |
| First Posted : | January 7, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 4, 2024 |
| Last Update Posted : | April 5, 2024 |